Vista Pharmaceuticals results
BSE: 524711Pharmaceuticals & BiotechnologySmall Cap
Last close ₹5.84up ₹0.36 (6.57%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹5.48.
52-week range of traded prices to 23 Oct 2026
₹5.32Low, 16 Sep 2026₹10.50High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹36 Cr3,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 1.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −28.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −32.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.27
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,933
Q1 results, quarter to Jun 2026
Standalone: the listed company alone, without its subsidiaries. ₹ crore.Vista Pharmaceuticals annual results and balance sheet
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period.
- ₹0.00 Cr−100.0% on a year agoChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax.
- −₹0.84 Cr
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax.
- −₹0.99 Cr
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line.
- −₹0.16
From revenue to net profit, ₹ crore
- Revenue0.0
- Employee costs−0.5
- Other expenses−0.3
- Operating profit−0.8
- Depreciation−0.2
- Other income0.0
- Finance costs−0.3
- Profit before tax−1.3
- Tax+0.3
- Net profit−1.0
Vista Pharmaceuticals results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Operating and net margin by quarter, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs.
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
| ₹ crore | Sep 2021Q2Filed 19 Nov | Dec 2021Q3Filed 18 Feb | Mar 2022Q4Filed 13 Jun | Jun 2022Q1Filed 6 Sep | Sep 2022Q2Filed 25 Nov | Dec 2022Q3Filed 16 Feb | Mar 2023Q4Filed 31 May | Jun 2023Q1Filed 12 Aug | Sep 2023Q2Filed 29 Nov | Dec 2023Q3Filed 22 Feb | Mar 2024Q4Filed 20 Jul | Jun 2024Q1Filed 16 Sep | Sep 2024Q2Filed 13 Nov | Dec 2024Q3Filed 13 Feb | Mar 2025Q4Filed 13 Jun | Jun 2025Q1Filed 13 Aug | Sep 2025Q2Filed 13 Nov | Dec 2025Q3Filed 13 Feb | Mar 2026Q4Filed 29 May | Jun 2026Q1Filed 14 Aug |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.29 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.98 | 3.47 | 1.70 | 3.13 | 1.80 | 2.49 | 2.56 | 3.23 | 1.52 | 1.46 | 2.42 | 0.00 | 0.00 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. | 0.59 | 0.27 | 0.31 | 0.20 | 0.15 | 0.33 | 2.38 | 2.90 | 4.64 | 3.45 | 2.87 | 2.57 | 3.32 | 4.07 | 4.14 | 2.63 | 4.90 | 5.42 | 7.06 | 0.84 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. | 0.26 | 0.10 | −0.01 | 0.00 | 0.00 | 0.00 | 1.23 | 1.97 | 3.21 | 2.21 | 1.50 | 1.60 | 1.55 | 2.50 | 2.69 | 1.50 | 1.46 | 2.26 | 0.00 | 0.00 |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. | 0.19 | 0.10 | 0.08 | 0.05 | 0.03 | 0.18 | 0.32 | 0.42 | 0.45 | 0.45 | 0.48 | 0.45 | 0.48 | 0.52 | 0.56 | 0.54 | 0.57 | 0.59 | 0.50 | 0.51 |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. | 0.13 | 0.07 | 0.24 | 0.15 | 0.12 | 0.15 | 0.83 | 0.52 | 0.99 | 0.78 | 0.89 | 0.52 | 1.29 | 1.06 | 0.89 | 0.59 | 2.87 | 2.57 | 6.56 | 0.33 |
| Operating profit before depreciationOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. | −0.31 | −0.16 | −0.31 | −0.20 | −0.15 | −0.33 | −1.38 | −0.92 | −1.17 | −1.74 | 0.26 | −0.78 | −0.82 | −1.52 | −0.91 | −1.11 | −3.44 | −3.01 | −7.06 | −0.84 |
| Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. | −106.9% | −145.6% | – | – | – | – | −137.0% | −46.5% | −33.7% | −102.4% | 8.4% | −43.3% | −33.0% | −59.4% | −28.2% | −73.2% | −235.1% | −124.3% | – | – |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 1.11 | 0.17 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.19 | 0.18 | 0.18 | 0.20 | 0.19 | 0.19 | 0.19 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. | −0.05 | −0.06 | 0.30 | 0.00 | 0.00 | 0.00 | 0.29 | 0.13 | 0.08 | 0.02 | 0.10 | 0.07 | 0.01 | 0.12 | 0.24 | 0.00 | 0.19 | 0.09 | 0.03 | 0.04 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. | 0.21 | 0.26 | 0.29 | 0.24 | 0.26 | 0.40 | 0.32 | 0.33 | 0.32 | 0.30 | 0.28 | 0.28 | 0.25 | 0.22 | 0.21 | 0.19 | 0.18 | 0.18 | 0.55 | 0.34 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.71 | −0.63 | −0.46 | −0.59 | −0.56 | −0.89 | −2.52 | −1.29 | −1.59 | −2.20 | −0.10 | −1.17 | −1.25 | −1.80 | −1.06 | −1.48 | −3.62 | −3.28 | −7.77 | −1.33 |
| Tax | 1.48 | 0.01 | −2.57 | 0.00 | −0.32 | 0.07 | – | −0.33 | 0.43 | −0.57 | −0.19 | −0.31 | −0.28 | −0.48 | 0.43 | −0.19 | −1.03 | −0.96 | −1.91 | −0.34 |
| Net profit | −2.19 | −0.63 | 2.11 | −0.59 | −0.24 | −0.96 | −3.87 | −0.95 | −2.02 | −1.63 | 0.09 | −0.86 | −0.97 | −1.32 | −1.50 | −1.29 | −2.59 | −2.32 | −5.86 | −0.99 |
| Other comprehensive incomeOther comprehensive income. Gains and losses booked straight to net worth rather than through profit, such as changes in the value of some investments, pension plans and currency translation. | 0.00 | 0.00 | 0.00 | −0.09 | −0.07 | −0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | −0.01 | 0.01 | 0.01 | 0.01 | −0.03 | 0.01 |
| Total comprehensive incomeTotal comprehensive income. Net profit plus other comprehensive income. | −2.19 | −0.63 | 2.11 | −0.68 | −0.31 | −0.98 | −3.86 | −0.95 | −2.02 | −1.63 | 0.09 | −0.85 | −0.97 | −1.30 | −1.51 | −1.28 | −2.58 | −2.31 | −5.89 | −0.98 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −767.5% | −580.4% | – | – | – | – | −385.4% | −48.2% | −58.2% | −95.6% | 2.9% | −47.7% | −39.0% | −51.7% | −46.3% | −85.0% | −177.0% | −95.9% | – | – |
| Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. | −₹0.60 | −₹0.17 | ₹0.56 | −₹0.18 | −₹0.08 | – | −₹1.05 | −₹0.46 | −₹0.46 | −₹0.33 | ₹0.02 | −₹0.15 | – | −₹0.07 | −₹0.26 | −₹0.22 | −₹0.42 | −₹0.41 | −₹0.91 | −₹0.16 |
| Diluted earnings per shareDiluted earnings per share. Earnings per share counting the shares that options, warrants and convertible bonds already granted would add, on today's share count after splits and bonuses. | −₹0.60 | −₹0.17 | ₹0.56 | −₹0.18 | −₹0.08 | – | −₹0.61 | −₹0.30 | −₹0.34 | −₹0.26 | ₹0.01 | −₹0.15 | – | −₹0.07 | −₹0.26 | −₹0.22 | – | −₹0.41 | −₹0.91 | −₹0.16 |
Earnings per share in rupees, restated for later splits and bonuses.
Filed results, as an XML file each
- Results for the quarter to Jun 2026 (opens in a new tab)Filed 14 Aug 2026
- Results for the quarter to Mar 2026 (opens in a new tab)Filed 29 May 2026
- Results for the quarter to Dec 2025 (opens in a new tab)Filed 13 Feb 2026
- Results for the quarter to Sep 2025 (opens in a new tab)Filed 13 Nov 2025
16 earlier filings
- Results for the quarter to Jun 2025 (opens in a new tab)Filed 13 Aug 2025
- Results for the quarter to Mar 2025 (opens in a new tab)Filed 13 Jun 2025
- Results for the quarter to Dec 2024 (opens in a new tab)Filed 13 Feb 2025
- Results for the quarter to Sep 2024 (opens in a new tab)Filed 13 Nov 2024
- Results for the quarter to Jun 2024 (opens in a new tab)Filed 16 Sep 2024
- Results for the quarter to Mar 2024 (opens in a new tab)Filed 20 Jul 2024
- Results for the quarter to Dec 2023 (opens in a new tab)Filed 22 Feb 2024
- Results for the quarter to Sep 2023 (opens in a new tab)Filed 29 Nov 2023
- Results for the quarter to Jun 2023 (opens in a new tab)Filed 12 Aug 2023
- Results for the quarter to Mar 2023 (opens in a new tab)Filed 31 May 2023
- Results for the quarter to Dec 2022 (opens in a new tab)Filed 16 Feb 2023
- Results for the quarter to Sep 2022 (opens in a new tab)Filed 25 Nov 2022
- Results for the quarter to Jun 2022 (opens in a new tab)Filed 6 Sep 2022
- Results for the quarter to Mar 2022 (opens in a new tab)Filed 13 Jun 2022
- Results for the quarter to Dec 2021 (opens in a new tab)Filed 18 Feb 2022
- Results for the quarter to Sep 2021 (opens in a new tab)Filed 19 Nov 2021